Peter R. Galle

575 total citations
18 papers, 114 citations indexed

About

Peter R. Galle is a scholar working on Hepatology, Epidemiology and Surgery. According to data from OpenAlex, Peter R. Galle has authored 18 papers receiving a total of 114 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Hepatology, 8 papers in Epidemiology and 7 papers in Surgery. Recurrent topics in Peter R. Galle's work include Liver Disease Diagnosis and Treatment (8 papers), Liver Disease and Transplantation (7 papers) and Hepatocellular Carcinoma Treatment and Prognosis (7 papers). Peter R. Galle is often cited by papers focused on Liver Disease Diagnosis and Treatment (8 papers), Liver Disease and Transplantation (7 papers) and Hepatocellular Carcinoma Treatment and Prognosis (7 papers). Peter R. Galle collaborates with scholars based in Germany, Italy and Japan. Peter R. Galle's co-authors include Lorenza Rimassa, Carolin Czauderna, Nicola Personeni, Friedrich Foerster, Christian Labenz, Alexander K. Schuster, Joost Boeckmans, Simon Johannes Gairing, Marcus‐Alexander Wörns and Thomas Münzel and has published in prestigious journals such as Journal of Clinical Oncology, Journal of Hepatology and Annals of Oncology.

In The Last Decade

Peter R. Galle

16 papers receiving 113 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peter R. Galle Germany 5 63 44 25 24 24 18 114
Keisuke Koroki Japan 5 58 0.9× 28 0.6× 12 0.5× 20 0.8× 15 0.6× 17 89
Yehia I. Mohamed United States 9 79 1.3× 51 1.2× 41 1.6× 47 2.0× 27 1.1× 20 171
Maria Tampaki Greece 7 111 1.8× 94 2.1× 24 1.0× 27 1.1× 16 0.7× 15 168
Yoshiro Asahina Japan 9 56 0.9× 33 0.8× 45 1.8× 37 1.5× 22 0.9× 18 152
Undarmaa Tudev Mongolia 4 37 0.6× 46 1.0× 29 1.2× 29 1.2× 27 1.1× 5 111
Jigjidsuren Chinburen Mongolia 5 51 0.8× 44 1.0× 27 1.1× 17 0.7× 24 1.0× 9 108
Adelina Horhat Romania 8 85 1.3× 78 1.8× 24 1.0× 33 1.4× 16 0.7× 13 150
Hatim Karachiwala Canada 6 79 1.3× 45 1.0× 18 0.7× 58 2.4× 9 0.4× 21 147
Hadassa Hirschfield United States 4 61 1.0× 27 0.6× 32 1.3× 27 1.1× 26 1.1× 4 113

Countries citing papers authored by Peter R. Galle

Since Specialization
Citations

This map shows the geographic impact of Peter R. Galle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter R. Galle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter R. Galle more than expected).

Fields of papers citing papers by Peter R. Galle

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter R. Galle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter R. Galle. The network helps show where Peter R. Galle may publish in the future.

Co-authorship network of co-authors of Peter R. Galle

This figure shows the co-authorship network connecting the top 25 collaborators of Peter R. Galle. A scholar is included among the top collaborators of Peter R. Galle based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter R. Galle. Peter R. Galle is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Gairing, Simon Johannes, Julia Weinmann‐Menke, Bernhard Meyer, et al.. (2025). Impact of Frailty on the Prognosis of Patients With Liver Cirrhosis Undergoing Insertion of a TIPS. Alimentary Pharmacology & Therapeutics. 63(1). 109–118. 1 indexed citations
2.
Labenz, Christian, et al.. (2025). Ammonia Levels After Transjugular Intrahepatic Portosystemic Shunt Insertion Identify Patients at High Risk of Hepatic Encephalopathy. Clinical Gastroenterology and Hepatology. 1 indexed citations
5.
Labenz, Christian, Simon Johannes Gairing, Leonard Kaps, et al.. (2024). QuickStroop for screening for minimal hepatic encephalopathy in patients with cirrhosis. JHEP Reports. 7(3). 101298–101298.
6.
Gairing, Simon Johannes, Lisa Zarantonello, Philippe Sultanik, et al.. (2024). Proton pump inhibitor use and risk of hepatic encephalopathy: A multicentre study. JHEP Reports. 6(8). 101104–101104. 3 indexed citations
8.
Boeckmans, Joost, Maurice Stephan Michel, Oliver Tüscher, et al.. (2024). Inflammation in liver fibrosis and atrial fibrillation: A prospective population-based proteomic study. JHEP Reports. 6(10). 101171–101171. 7 indexed citations
9.
Fulgenzi, Claudia Angela Maria, Antonio D’Alessio, Hong Jae Chon, et al.. (2023). Neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) as prognostic biomarkers in unresectable hepatocellular carcinoma (HCC) treated with atezolizumab plus bevacizumab (atezo-bev).. Journal of Clinical Oncology. 41(4_suppl). 504–504. 1 indexed citations
10.
Nagel, Michael, Peter R. Galle, Jörn M. Schattenberg, et al.. (2023). Validation of the CLIF-C OF Score and CLIF-C ACLF Score to Predict Transplant-Free Survival in Patients with Liver Cirrhosis and Concomitant Need for Intensive Care Unit Treatment. Medicina. 59(5). 866–866. 3 indexed citations
11.
Arslanow, Anita, Harald Binder, Peter R. Galle, et al.. (2023). How do (false) positively screened patients experience a screening programme for liver cirrhosis or fibrosis in Germany? A qualitative study. Health Expectations. 26(5). 1923–1930. 3 indexed citations
12.
Witzel, Hagen Roland, Arndt Weinmann, F. Bartsch, et al.. (2023). Reduced Lipid Peroxidation Predicts Unfavorable Prognosis in Hepatocellular Carcinoma, but Not Intrahepatic Cholangiocarcinoma. Biomedicines. 11(9). 2471–2471. 2 indexed citations
13.
Gairing, Simon Johannes, Leonard Kaps, Michael Nagel, et al.. (2023). Elevated serum levels of glial fibrillary acidic protein are associated with covert hepatic encephalopathy in patients with cirrhosis. JHEP Reports. 5(4). 100671–100671. 7 indexed citations
14.
Becker, Diana, Marco Groth, Nils Hartmann, et al.. (2023). Deletion of Cd44 Inhibits Metastasis Formation of Liver Cancer in Nf2-Mutant Mice. Cells. 12(9). 1257–1257. 4 indexed citations
15.
Stoehr, Fabian, Roman Kloeckner, Daniel Pinto dos Santos, et al.. (2022). Radiomics-Based Prediction of Future Portal Vein Tumor Infiltration in Patients with HCC—A Proof-of-Concept Study. Cancers. 14(24). 6036–6036. 1 indexed citations
16.
Rimassa, Lorenza, Nicola Personeni, Carolin Czauderna, Friedrich Foerster, & Peter R. Galle. (2020). Systemic treatment of HCC in special populations. Journal of Hepatology. 74(4). 931–943. 72 indexed citations
17.
Dignaß, Axel, Siegbert Faiss, Peter R. Galle, et al.. (2012). Boceprevir-Nutzenbewertung des Instituts für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) gemäß § 35a SGB V (Dossierbewertung). Zeitschrift für Gastroenterologie. 50(1). 20–21. 2 indexed citations
18.
Galle, Peter R., et al.. (1977). Isolated complete dislocation of the talus. The Journal of Trauma: Injury, Infection, and Critical Care. 17(11). 892–892. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026